Glucagon-like peptide-1 receptor agonist treatment is associated with lower frequency of diabetic peripheral neuropathy and neuropathic pain in type 2 diabetes.
- DOI
- 10.1097/j.pain.0000000000004104
- Published
- 2026 Aug 20
- Container
- Pain
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/j.pain.0000000000004104,
title = {Glucagon-like peptide-1 receptor agonist treatment is associated with lower frequency of diabetic peripheral neuropathy and neuropathic pain in type 2 diabetes.},
author = {Falco P and Di Flaviani A and Galosi E and Angotti S and De Stefano G and Di Pietro G and Di Stefano G and D'Onofrio L and Evangelisti E and Leone C and Litewczuk D and Arendt-Nielsen L and Buzzetti R and Spallone V and Truini A},
year = {2026},
journal = {Pain},
doi = {10.1097/j.pain.0000000000004104},
url = {https://doi.org/10.1097/j.pain.0000000000004104}
}RIS
TY - JOUR TI - Glucagon-like peptide-1 receptor agonist treatment is associated with lower frequency of diabetic peripheral neuropathy and neuropathic pain in type 2 diabetes. AU - Falco P AU - Di Flaviani A AU - Galosi E AU - Angotti S AU - De Stefano G AU - Di Pietro G AU - Di Stefano G AU - D'Onofrio L AU - Evangelisti E AU - Leone C AU - Litewczuk D AU - Arendt-Nielsen L AU - Buzzetti R AU - Spallone V AU - Truini A PY - 2026 JO - Pain DO - 10.1097/j.pain.0000000000004104 UR - https://doi.org/10.1097/j.pain.0000000000004104 ER -
APA
P, F., A, D. F., E, G., S, A., G, D. S., G, D. P., G, D. S., L, D., E, E., C, L., D, L., L, A., R, B., V, S., & A, T. (2026). Glucagon-like peptide-1 receptor agonist treatment is associated with lower frequency of diabetic peripheral neuropathy and neuropathic pain in type 2 diabetes.. Pain. https://doi.org/10.1097/j.pain.0000000000004104
Source records
- pubmed · retrieved 2026-09-26T19:27:17.236Z